Table 2.
Representative NPs enhance sensitivity or reverse drug resistance in cancers by regulating redox balance
| NPs | Plant Sources | Drugs | Cancer Types | Cells | Mechanisms | Synergistic | Ref |
|---|---|---|---|---|---|---|---|
| Oridonin | Rabdosia rubescens | Cisplatin | Esophageal | KYSE30 | GSH↓, ROS↑, DNA damage ↑ | Sensitization | [150] |
| Oridonin | Rabdosia rubescens | 5-FU | Renal | 786-O | GSH↓, ROS↑, MAPK↑ | Sensitization | [151] |
| Oridonin | Rabdosia rubescens | Arsenic trioxide | Liver | Bel7402 | ROS↑, NF-κB↓, MMP↓, p-p38↑, p-ERK1↑, p-JNK↑ | Sensitization | [254] |
| Oridonin | Rabdosia rubescens | Cetuximab | Laryngeal | HEp-2, Tu212 | ROS↑, JNK↑ | Sensitization | [255] |
| Plumbagin | Plumabago zeylanica L | TRAIL | Leukemia | Kasumi-1 | GSH↓, ROS↑, DR4/5↑, Caspase8↑ | Sensitization | [153] |
| Plumbagin | Plumabago zeylanica L | BAY-876 | Lung | H1299, H1944, H1975, A549 | TrxR1↓, O2• −↑, ROS↑ | Sensitization | [164] |
| Plumbagin | Plumabago zeylanica L | Cisplatin | Tongue | CAL27/CDDP | ROS↑, Mitochondrial superoxide↑, AKT/mTOR↓ | Reverse resistance | [256] |
| Embelin | Embelia ribes | TRAIL | Breast | SUM149 | GSH↓, SOD1↓, ROS↑ | Sensitization | [154] |
| Emodin | Rhubarb | Cisplatin | Bladder | T24, J82 | GSH↓, ROS↑, MRP1↓ | Sensitization | [155] |
| Emodin | Rhubarb | Platinum | Gallbladder | SGC996 | GSH↓, MRP1↓, ROS↑ | Sensitization | [257] |
| Emodin | Rhubarb | Cisplatin | Endometrial | Ishikawa, HEC-IB | NOX↓, P-gp↓, MRP↓, BCRP↓, ROS↓ | Sensitization | [172] |
| Emodin | Rhubarb | Cisplatin | Ovarian | COC1/DDP | ROS↑, GS-X pump↓, MRP1↓ | Reverse resistance | [258] |
| Quercetin | Quercetum | Tamoxifen | Breast | MDA-MB-231, MCF-7 | GSH↓, MMP↓ | Sensitization | [156] |
| Quercetin | Quercetum | Cisplatin | Ovarian | SKOV3/CDDP | Trx1/2↓, TrxR1↓, ROS↑ | Reverse resistance | [165] |
| Quercetin | Quercetum | 5-FU | Colorectal | HCT116 | SOD↓, CAT↓, GPX↓, GR↓, Nrf2/HO-1↓, ROS↓ | Reverse resistance | [179] |
| Quercetin | Quercetum | Cisplatin | Ovarian | SKOV3/CDDP | SOD2↓, CAT↓, GPX1↓, HO-1↓, Nrf2↓ | Reverse resistance | [180] |
| Quercetin | Quercetum | Doxorubicin, Cyclophosphamide | Breast | MDA-MB-231 | ROS↓, ERK1/2↓, Caspase3↑ | Sensitization | [183] |
| Artesunate | Artemisia annua | Sunitinib | Renal | KTCTL-26 | GPX4↓, GSH↓, ROS↑ | Reverse resistance | [259] |
| Piperlongumine | Piper longum L | Oxaliplatin | Gastric | SGC-7901, BGC-823 | TrxR1↓, ROS↑, DNA damage↑, p38/JNK↑ | Sensitization | [161] |
| Piperlongumine | Piper longum L | TRAIL | Breast | MDA-MB-231 | ROS↑, p38/JNK↑, DR5↑ | Sensitization | [260] |
| Piperlongumine | Piper longum L | Sorafenib | Liver | HCCLM3, SMMC7721 | ROS↑, p-AMPK↑ | Sensitization | [261] |
| Shikonin | Lithospermum erythrorhizon | Gefitinib | Lung | H1650,H1975 | TrxR↓, NADPH↓, GSH/GSSG↓, ROS↑, Caspase3↑ | Reverse resistance | [163] |
| Shikonin | Lithospermum erythrorhizon | Cisplatin | Ovarian | A2780/DDP, SKOV3/DDP | GPX4↓, ROS↑, LPO↑ | Reverse resistance | [262] |
| Shikonin | Lithospermum erythrorhizon | Cabazitaxel | Prostate | DU145, PC-3 | ROS↑, MMP↓ | Sensitization | [263] |
| Oleanolic acid (OLO-2) | Araliaceae | Cisplatin | Lung | A549/CDDP | TrxR↓, ROS↑, NF-κB↓ | Reverse resistance | [166] |
| Oleanolic acid | Araliaceae | Sorafenib | Liver | Huh7, HepG2 | ROS↑, LPO↑ | Sensitization | [264] |
| Sanguinarine | Sanguinaria canadensis | Gefitinib | Lung | H1975 | NOX3↑, NADP+/NADPH↑, O2• −↑, H2O2↑, ROS↑ | Reverse resistance | [169] |
| Sanguinarine | Sanguinaria canadensis | Cisplatin | Ovarian | A2780/R | GSH↓ | Reverse resistance | [265] |
| Ginsenoside Ro | Ginseng | 5-FU | Esophageal | ECA-109, TE-1, CT-26 | NOX↑, NCF1↑, CYBB↑, ROS↑ | Sensitization | [170] |
| Ginsenoside Rd | Ginseng | Cisplatin | Lung | A549/DDP | Nrf2↓, HO-1↓, NQO1↓, MDR1↓, MRP1↓ | Reverse resistance | [177] |
| Baicalin | Scutellaria baicalensis | 5-FU | Gastric | AGS, SGC-7901 | NOX1↑, GPX4↓, COX2↑, ROS↑ | Sensitization | [118] |
| Baicalin | Scutellaria baicalensis | Doxorubicin | Breast | MDA-MB-23, MCF-7 | Oxidative stress↑, ROS↑, SOD↓, MMP↓ | Sensitization | [266] |
| Ursolic Acid | Rosmarinus officinalis | Oxaliplatin | Colorectal | HCT8, SW480 | NADPH↑, ROS↑, P-gp↓, MRP↓, BCRP↓ | Sensitization | [171] |
| Ursolic Acid | Rosmarinus officinalis | Doxorubicin | Breast | MCF-7/ADR | ROS↑, DNA damage↑, p-AMPK↑, p-mTOR↓ | Reverse resistance | [267] |
| Ursolic Acid | Rosmarinus officinalis | Sorafenib | Liver | Hep 3B | ROS↑, SLC7A11↓ | Sensitization | [268] |
| Wogonin | Scutellaria baicalensis |
Hydroxycampto- thecin, Cisplatin, Etoposide |
Liver | HepG2 | Nrf2↓, HO-1↓, NQO1↓, ROS↑, MRP↓ | Sensitization | [174] |
| Wogonin | Scutellaria baicalensis | Doxorubicin | Breast | MCF-7/DOX | Nrf2↓, HO-1↓, NQO1↓ | Reverse resistance | [175] |
| Wogonin | Scutellaria baicalensis | Cisplatin | Head and neck | HN4-cisR, HN9-cisR | Nrf2↓, GSTP1↓, GSH/GSSG↓, ROS↑, p-JNK↑ | Reverse resistance | [176] |
| Wogonin | Scutellaria baicalensis | TRAIL | Prostate | LNCaP | ROS↑, p53↑ | Sensitization | [269] |
| Berberine | Rhizoma coptidis | Lapatinib | Breast | BT-474LapR | Nrf2↓, ROS↑ | Reverse resistance | [178] |
| Berberine | Rhizoma coptidis | Niraparib | Ovarian | A2780, HEY, HO8910 | Oxidative stress↑, DNA damage↑ | Sensitization | [270] |
| Parthenolide | Tanacetum parthenium | Mitoxantrone, Doxorubicin | Breast | MDA-MB231 | Nrf2↓, CAT↓, MnSOD↓, HSP70↓, ROS↑ | Reverse resistance | [181] |
| Triptolide | Tripterygium wilfordii | Cisplatin | Ovarian | SKOV3PT | ROS↑, NF-κB↓, Caspase3↑ | Reverse resistance | [182] |
| Triptolide | Tripterygium wilfordii | Doxorubicin, Imatinib | Leukemia | HL60/A, K562/G | Nrf2↓, NQO1↓, GSR↓, HO-1↓ | Reverse resistance | [271] |
| Triptolide | Tripterygium wilfordii | Gemcitabine | Bladder | UMUC3, EJ | CAT↓, SOD2↓, ROS↑ | Sensitization | [272] |
| Brusatol | Brucea javanica | Gemcitabine | Pancreatic | PANC-1 | Nrf2↓, ROS↑ | Sensitization | [273] |
| Brusatol | Brucea javanica | Trastuzumab | Ovarian, Breast | SK-OV-3, BT-474 | Nrf2/HO-1↓, HER2-AKT/ERK1/2↓ | Sensitization | [274] |
| Resveratrol | Berries | 5-FU | Colorectal | HT29, SW480, SW620 | SOD↑, CAT↓, GPX↓, ROS↑, LPO↑ | Sensitization | [184] |
| Resveratrol | Berries | Platinum | Breast, Choriocarcinoma | MDA-MB-231, JEG-3 | O2• −↑, H2O2↑, NO2−↑ | Sensitization | [185] |
| Resveratrol | Berries | Temozolomide | Glioblastoma | SHG44 | ROS↑, AMPK↑, mTOR↓, MMP↓ | Sensitization | [186] |
| Resveratrol | Berries | Temozolomide | Glioblastoma | U87MG, GBM8401 | ROS↓ | Sensitization | [187] |
| EGCG | Green tea | Gefitinib, Osimertinib | Lung | H1975 (GR) | OXPHOS↑, ROS↑ | Reverse resistance | [188] |
| EGCG | Green tea | TRAIL | Renal | 786-O | ROS↑ | Sensitization | [189] |
| EGCG | Green tea | Irinotecan | Colorectal | HCT116,RKO | ER stress↑, ROS↓ | Sensitization | [190] |
| EGCG | Green tea | Doxorubicin | Oral | KB-A-1 | Redox↓, Antioxidation↑ | Reverse resistance | [191] |
| Curcumin | Curcuma longa | Docetaxel, Vincristine | Lung | A549/D16, A549/V16 | p-ERK↑, p-p38↑, ROS↑ | Reverse resistance | [275] |
| Mitocurcumin | Curcuma longa | Cytarabine | Leukemia | MOLM13 | Oxidative stress↑, ROS/p21/CHK1↑, JNK/p38↑ | Reverse resistance | [276] |
| Genistein | Genista tinctoria L | Topotecan | Prostate | LNCaP | ROS↑, Caspase3/9↑ | Sensitization | [277] |
| Genistein | Genista tinctoria L | Arsenic trioxide | Liver | HepG2, Hep3B, SK-Hep-1 | ROS↑, Caspase3/9↑ | Sensitization | [278] |
| Gallic Acid | Gallnut | Cisplatin | Lung | H446 | ROS↑, MMP↓, p53↑ | Sensitization | [279] |
| Gallic Acid | Gallnut | Paclitaxel | Ovarian | A2780, A2780AD | ROS↑, p-ERK↓ | Reverse resistance | [280] |
| β-Elemene | Curcumae Rhizoma | Cisplatin | Bladder | T24 | ROS↑, AMPK↑ | Sensitization | [281] |
| β-Elemene | Curcumae Rhizoma | Cetuximab | Colorectal | HCT116, Lovo | GSH↓, MDA↑, GPX4↓, GLS↓, SLC7A11↓, ROS↑ | Sensitization | [223] |
| Apigenin | Celery | Doxorubicin | Liver | BEL-7402/ADM | Nrf2↓, HO-1↓, ROS↑, PI3K/Akt↓ | Reverse resistance | [282] |
| Saikosaponins | Bupleurum radix | Cisplatin | Cervical, Ovarian, Lung | Hela, Siha, SKOV3, A549 | ROS↑ | Sensitization | [283] |
| Rhein | Rhubarb | Oxaliplatin | Pancreatic | PANC-1, MIAPaca-2 | ROS↑, MDA↑, PI3K/Akt↓ | Sensitization | [284] |
| Mangostin | Mangosteen tree | Cisplatin | Cervical | HeLa | ROS↑ | Sensitization | [285] |
| Hederagenin | Hedera helix | Cisplatin, Paclitaxel | Lung | H1299, H1975 | ROS↑, MAPK↑ | Sensitization | [286] |
| Hederagenin | Hedera helix | Cisplatin | Head and neck | HN3-cisR, HN9-cisR | Nrf2↓, HO-1↓, NQO1↓, xCT↓, GSH↓, ROS↑, p53↑ | Reverse resistance | [287] |
| Tanshinone IIA | Salvia miltiorrhiza | TRAIL | Ovarian | TOV-21G | ROS↑, p-JNK↑, CHOP↑, DR5↑ | Sensitization | [288] |
| Andrographolide | Andrographis paniculate | Cisplatin | Colorectal | HCT116, HT29 | ROS↑, MDA↑, ER Stress↑ | Sensitization | [289] |
| Andrographolide | Andrographis paniculate | TRAIL | Prostate | PC-3 | ROS↑, p53↑, DR4↑ | Sensitization | [290] |
| Honokiol | Magnolia officinalis | Cabozantinib | Renal | 786–0, ACHN | Nrf2↓, HO-1↓, Oxidative stress↑, ROS↑ | Sensitization | [291] |
| Camptothecin | Camptotheca acuminata | TRAIL | Liver | Hep 3B | ROS↑, DR5↑ | Sensitization | [292] |
| Arachidin-1 | Peanut | Paclitaxel | Breast | MDA-MB-231 | ROS↑, Mitochondrial oxidative stress↑, p53↑ | Sensitization | [293] |
| Glaucocalyxin B | Rabdosia japonica | Cisplatin | Ovarian | A2780, A2780/DDP | ROS↑, p-JNK↑, DNA damage↑ | Sensitization | [294] |
| Alantolactone | Inula helenium | Oxaliplatin | Colorectal | HCT116, RKO | ROS↑, p38↑, p-JNK↑ | Sensitization | [295] |
| Salvianolic acid B | Salvia miltiorrhiza | Vincristine, 5-FU, Cisplatin | Colorectal | HCT8/VCR | ROS↑, P-gp↓, MDR1↓ | Reverse resistance | [296] |
| Gypenosides | Gynostemma pentaphyllum | 5-FU | Colorectal | SW-480 | ROS↑, DNA damage↑, p53↑ | Sensitization | [297] |
| Dihydroartemisinin | Artemisia annua | Doxorubicin | Cervical | HeLa, SiHa | MDA↑, GSH↓ | Sensitization | [298] |
| Thymoquinone | Nigella sativa | Cisplatin | Oral | SCC-25 | ROS↑, LPO↑, DNA damage↑ | Sensitization | [299] |